生物学前疾病轨迹与严重喘的发病率负担和生物治疗反应有关
Marianne Baastrup Soendergaard1,2, Frederikke Hjortdahl1,2, Susanne Hansen1
1Department of Respiratory Medicine, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark.
The European respiratory journal
|January 9, 2025
概括
在生物治疗前确定长期严重喘轨迹,可以发现不同的患者群体. 了解这些模式对于优化生物治疗和改善严重喘管理结果至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 数据科学数据科学数据科学
背景情况:
- 生物疗法可为严重喘提供缓解,但治疗前的疾病进展情况尚不清楚.
- 在生物启动之前识别不同的疾病轨迹对于预测治疗反应至关重要.
研究的目的:
- 在开始生物治疗的严重喘患者中识别长期疾病轨迹.
- 调查这些轨迹,疾病负担和生物疗法疗效之间的关联.
主要方法:
- 来自丹麦严重喘登记处的755名患者 (2016-2022) 的回顾性分析,使用1995年的处方数据.
- 吸入性皮质类固醇强度的序列分析和无监督的聚类来定义生前轨迹.
主要成果:
- 确定了三个轨迹:"慢性严重喘" (26%),"逐渐发作的严重喘" (35%) 和"最近突然发作的严重喘" (39%).
- 与其他患者 (29-32%) 相比",慢性严重喘"患者的疾病持续时间更长,损伤更大,缓解率更低 (17%).
- 疾病持续时间和活动与喘和并发症负担相关.
结论:
- 生物学前严重喘轨迹与疾病负担和治疗结果有关.
- 早期干预策略对于减轻严重喘不可逆转的不良影响至关重要.
相关概念视频
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177


